NASDAQ
22.11.24
22:00 Uhr
0,108 US-Dollar
+0,003
+2,38 %
+2,38 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | US STOCKS Tapestry, Eyenovia, Viking Therapeutics | 6 | Reuters | ||
| EYENOVIA Aktie jetzt für 0€ handeln | |||||
| Fr | Eyenovia rises on additional cost-cutting actions, delayed debt repayment | 1 | Reuters | ||
| Fr | Eyenovia secures debt payment deferral from Avenue Capital | 1 | Investing.com | ||
| Fr | Eyenovia sichert sich Zahlungsaufschub für Schulden von Avenue Capital | 2 | Investing.com Deutsch | ||
| Fr | Eyenovia, Inc.: Eyenovia Provides Update on Restructuring Efforts | 74 | GlobeNewswire (Europe) | Avenue Capital agrees to Company's deferral of principal and interest payments on its outstanding debt until the end of February 2025 Eyenovia continues to evaluate a broad range of strategic alternatives... ► Artikel lesen | |
| Mi | EYENOVIA, INC. - 8-K, Current Report | 7 | SEC Filings | ||
| Mo | Eyenovia Stock Tumbles on Termination of Phase III Myopia Study | 2 | Zacks | ||
| 15.11. | Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline | 3 | Benzinga.com | ||
| 15.11. | Eyenovia hits record low after discontinuing late-stage eye drug study | 10 | Reuters | ||
| 15.11. | Eyenovia plunges as late-stage trial for myopia treatment fails | 1 | Seeking Alpha | ||
| 15.11. | US STOCKS Alibaba, Palantir, Eyenovia | 28 | Reuters | ||
| 15.11. | Eyenovia discontinues late-stage eye drug study, shares fall | 12 | Reuters | ||
| 15.11. | Eyenovia halts myopia study after missing primary endpoint | 2 | Investing.com | ||
| 15.11. | Eyenovia, Inc.: Eyenovia Provides Update on Phase 3 CHAPERONE Study | 105 | GlobeNewswire (Europe) | A review of study data by an independent Data Review Committee found that CHAPERONE is not meeting its primary three-year efficacy endpoint Company to discontinue study, review full data set, and... ► Artikel lesen | |
| 13.11. | EYENOVIA, INC. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 13.11. | Eyenovia Inc reports results for the quarter ended September 30 - Earnings Summary | 5 | Reuters | ||
| 12.11. | Eyenovia GAAP EPS of -$0.11 in-line, revenue of $1.62M beats by $1.51M | 1 | Seeking Alpha | ||
| 12.11. | EYENOVIA, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.11. | EYENOVIA, INC. - 8-K, Current Report | - | SEC Filings | ||
| 11.11. | Earnings Outlook For Eyenovia | 3 | Benzinga.com |
Seite:
1 2 3 4 Weiter >>
71 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS | 8,950 | -3,24 % | Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update | BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported... ► Artikel lesen | |
| ROCKET LAB USA | 22,350 | 0,00 % | Why Rocket Lab Stock Rocketed Again on Friday | ||
| BOIRON | 27,400 | -7,12 % | BOIRON: EVOLUTION OF GOVERNANCE | July 3rd, 2024
The Board of Directors of Laboratoires BOIRON, meeting today under the chairmanship of Thierry BOIRON, has enacted an evolution of the Group's governance.
In this context, Thierry... ► Artikel lesen | |
| HARROW | 42,940 | -2,16 % | Harrow subsidiary wins $34.9 million in trademark case | ||
| MEDICINOVA | 1,700 | 0,00 % | MediciNova, Inc.: MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders | LA JOLLA, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| ESSA PHARMA | 1,840 | +4,55 % | ESSA Pharma: NBC-Anlegerclub feiert schnelle +23% Rendite! | Der No Brainer Club (NBC) hat erneut sein Gespür für unterbewertete Biotech-Perlen unter Beweis gestellt. Mit ESSA Pharma konnten Mitglieder in diesem fulminanten Biotech-Herbst innerhalb weniger Tage... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,550 | +0,11 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Anaphylm (epinephrine) Sublingual Film pre-NDA meeting scheduled for fourth quarter 2024AQST-108 (epinephrine) Topical Gel pre-IND meeting scheduled for fourth quarter 2024Libervant® (diazepam) Buccal... ► Artikel lesen | |
| SHINECO | 2,710 | +3,83 % | Shineco, Inc.: Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement | BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today... ► Artikel lesen | |
| LYRA THERAPEUTICS | 0,186 | +2,36 % | Lyra Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary | ||
| REVIVA PHARMACEUTICALS | 1,180 | -4,84 % | Reviva Pharmaceuticals: Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights | - 108 patients have completed 1-year of treatment in 1-year open-label extension (OLE) trial - - Vocal biomarker speech latency data from RECOVER trial reinforce brilaroxazine's improvement on negative... ► Artikel lesen | |
| CYANOTECH | 0,260 | 0,00 % | Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2025 | KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 1,060 | -1,85 % | Cumberland Pharma-Aktie erreicht 52-Wochen-Tief bei 1,07 US-Dollar | ||
| NUTRIBAND | 4,640 | +5,45 % | Nutriband, Inc.: Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application | ORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that theChinese National Intellectual Property Administrant (CNIPA) has fully issued its patent titled... ► Artikel lesen | |
| BAYER | 19,802 | +1,46 % | Tiefster Stand seit 20 Jahren: Bayer: Es kann sogar noch schlimmer kommen! | © Foto: Oliver Berg/dpaDie Anteile von Bayer sind am Donnerstag auf den tiefsten Stand seit mehr als 20 Jahren gefallen. Kann es schlimmer jetzt nicht mehr kommen? Oh doch!Für die Aktie der ehemaligen... ► Artikel lesen | |
| MERCK KGAA | 141,75 | +2,49 % | Merck Aktie: Abwärtsdruck erhöht sich |
Das Unternehmen EYENOVIA INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,108 Euro und damit +2,38 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EYENOVIA INC finden Sie auf Wallstreet Online.
